Arndt Vogel· @ArndtVogel · X·· 16 小时前评分70
正文 · 原文
🔥Presidential session at ESMO 2026 🔥
HARMONi-GI1 ph-3: Ivonescimab + CTx vs durvalumab + CTx as 1L for BTC
#ESMO26 #ESMOAmbassadors
👉ORR: 53.8 vs. 32.5 %
👉mPFS: 8.4 vs 5.8 mo
👉mOS: 14.9 vs. 12.1 mo
🧐 Very promising Chinese data, would be great to see data in a global population
@myESMO @ASCO
19 浏览 · 1 赞 · 0 转发 · 0 回复
来源：Arndt Vogel · x.com